Have Insiders Been Selling Slack Technologies, Inc. (NYSE:WORK) Shares?

    It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So before you buy or sell Slack Technologies, Inc. (NYSE:WORK), you may well want to know whether insiders have been buying or selling.

    Advertisement

    What Is Insider Buying?

    It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern insider transactions, and certain disclosures are required.

    We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

    View our latest analysis for Slack Technologies

    Slack Technologies Insider Transactions Over The Last Year

    In the last twelve months, the biggest single sale by an insider was when the Co-Founder, Daniel Butterfield, sold US$34m worth of shares at a price of US$41.66 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (US$30.76). So it may not shed much light on insider confidence at current levels.

    In the last twelve months insiders netted US$41m for 1.1m shares sold. In the last year Slack Technologies insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

    NYSE:WORK Recent Insider Trading, August 16th 2019
    NYSE:WORK Recent Insider Trading, August 16th 2019

    Insiders at Slack Technologies Have Sold Stock Recently

    The last three months saw significant insider selling at Slack Technologies. In total, insiders dumped US$41m worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

    Does Slack Technologies Boast High Insider Ownership?

    Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. It's great to see that Slack Technologies insiders own 13% of the company, worth about US$2.0b. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

    So What Do The Slack Technologies Insider Transactions Indicate?

    Insiders haven't bought Slack Technologies stock in the last three months, but there was some selling. And even if we look to the last year, we didn't see any purchases. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

    But note: Slack Technologies may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

    For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

    We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

    If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

    Advertisement

    Weekly Picks

    LO
    Lou_Basenese
    OPTH logo
    Lou_Basenese on Optimi Health ·

    The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

    Fair Value:US$1157.5% undervalued
    46 users have followed this narrative
    2 users have commented on this narrative
    7 users have liked this narrative
    WE
    WealthAP
    NOVO B logo
    WealthAP on Novo Nordisk ·

    Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

    Fair Value:DKK 407.7721.4% undervalued
    65 users have followed this narrative
    0 users have commented on this narrative
    8 users have liked this narrative
    VA
    ValueInvestingSubstack
    ZTS logo
    ValueInvestingSubstack on Zoetis ·

    Zoetis down -50% over the past year

    Fair Value:US$92.9218.9% undervalued
    22 users have followed this narrative
    0 users have commented on this narrative
    9 users have liked this narrative
    CE
    CentryResearch
    LEU logo
    CentryResearch on Centrus Energy ·

    Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

    Fair Value:US$19013.7% undervalued
    24 users have followed this narrative
    0 users have commented on this narrative
    10 users have liked this narrative

    Updated Narratives

    AN
    AnimalDoctorKwon
    CSBT.F logo
    AnimalDoctorKwon on Kuros Biosciences ·

    How a Mispriced Medtech Engine is Disrupting $5,000 Bone Graft Giants.

    Fair Value:US$342.1892.5% undervalued
    1 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    EU
    European_Hidden_Gem_Stocks
    RZLV logo
    European_Hidden_Gem_Stocks on Rezolve AI ·

    ⚡ Two-Minute Drill: Rezolve AI - The AI That Doesn't Recommend Products. It Buys Them.

    Fair Value:US$80.7897.2% undervalued
    1 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    EU
    European_Hidden_Gem_Stocks
    NET logo
    European_Hidden_Gem_Stocks on Netcall ·

    ⚡ Two-Minute Drill: Netcall PLC - This £200M AI Stock Is Already Running the NHS

    Fair Value:UK£2.1745.6% undervalued
    2 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative

    Popular Narratives

    CU
    MSFT logo
    CubanEros on Microsoft ·

    A wonderful business at reasonable price.

    Fair Value:US$419.919.1% undervalued
    81 users have followed this narrative
    0 users have commented on this narrative
    6 users have liked this narrative
    BE
    PYPL logo
    benjamin_lvieq on PayPal Holdings ·

    PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

    Fair Value:US$6513.6% undervalued
    71 users have followed this narrative
    2 users have commented on this narrative
    11 users have liked this narrative
    OS
    oscargarcia
    NVDA logo
    oscargarcia on NVIDIA ·

    The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

    Fair Value:US$28026.1% undervalued
    185 users have followed this narrative
    9 users have commented on this narrative
    15 users have liked this narrative

    Trending Discussion

    DE
    TDOC logo
    derek_3wsdg on Teladoc Health ·

    You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

    1
    |
    0